BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7998111)

  • 1. Use of CD3 antibodies in transplantation and autoimmune diseases.
    Chatenoud L
    Transplant Proc; 1994 Dec; 26(6):3191-3. PubMed ID: 7998111
    [No Abstract]   [Full Text] [Related]  

  • 2. Monoclonal antibodies in organ transplantation.
    Valdés RH
    Transplant Proc; 1996 Dec; 28(6):3293. PubMed ID: 8962277
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-CD3 antibodies.
    Chatenoud L; Bach JF
    Immunol Ser; 1993; 59():175-91. PubMed ID: 8461387
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunosuppressive effects of anti-CD3 MAb and soluble co-stimulatory molecules.
    Bluestone JA; Bruce D; Peterson L; Thistlethwaite JR; Josephson M; Zeng Y; Linsley PS; Lenschow DJ
    Transplant Proc; 1993 Feb; 25(1 Pt 1):546-7. PubMed ID: 8438407
    [No Abstract]   [Full Text] [Related]  

  • 5. In vivo T cell activation properties of anti-T cell monoclonal antibodies.
    Ferran C; Bach JF; Chatenoud L
    Exp Nephrol; 1993; 1(2):83-9. PubMed ID: 8081961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel humanized anti-CD3 antibodies induce a predominantly immunoregulatory profile in human peripheral blood mononuclear cells.
    Silva HM; Vieira PM; Costa PL; Pimentel BM; Moro AM; Kalil J; Maranhão AQ; Coelho V; Brigido MM
    Immunol Lett; 2009 Aug; 125(2):129-36. PubMed ID: 19573559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory monitoring of therapy with OKT3 and other murine monoclonal antibodies.
    Colvin RB; Preffer FI
    Clin Lab Med; 1991 Sep; 11(3):693-714. PubMed ID: 1934971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Devising murine models to better adapt clinical protocols: sequential low-dose treatment with anti-CD3 and anti-CD4 monoclonal antibodies to prevent fully mismatched allograft rejection.
    Campos HH; Bach JF; Chatenoud L
    Transplant Proc; 1993 Feb; 25(1 Pt 1):798-9. PubMed ID: 8438486
    [No Abstract]   [Full Text] [Related]  

  • 9. Modulation of antigen-specific T cell response by a non-mitogenic anti-CD3 antibody.
    Li J; Davis J; Bracht M; Carton J; Armstrong J; Gao W; Scallon B; Fung R; Emmell E; Zimmerman M; Griswold DE; Li L
    Int Immunopharmacol; 2006 Jun; 6(6):880-91. PubMed ID: 16644473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Muromonab CD3].
    Akioka Y; Hattori M; Ito K
    Nihon Rinsho; 2005 May; 63 Suppl 5():747-50. PubMed ID: 15954439
    [No Abstract]   [Full Text] [Related]  

  • 11. Biological reagents for immunosuppressants.
    Soulillou JP
    Transplant Proc; 1995 Feb; 27(1):106-8. PubMed ID: 7878803
    [No Abstract]   [Full Text] [Related]  

  • 12. Otelixizumab in the treatment of type 1 diabetes mellitus.
    Sprangers B; Van der Schueren B; Gillard P; Mathieu C
    Immunotherapy; 2011 Nov; 3(11):1303-16. PubMed ID: 22053883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A model of human anti-T-cell monoclonal antibody therapy in SCID mice engrafted with human peripheral blood lymphocytes.
    Tsuchida M; Brown SA; Tutt LM; Tan J; Seehafer DL; Harris JP; Xun CQ; Thompson JS
    Clin Transplant; 1997 Oct; 11(5 Pt 2):522-8. PubMed ID: 9361954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological immunosuppressants: the way to clinical transplantation tolerance.
    Chatenoud L
    Transplant Proc; 1997; 29(1-2):51-5. PubMed ID: 9123108
    [No Abstract]   [Full Text] [Related]  

  • 15. Induction of immunological tolerance using monoclonal antibodies: applications to organ transplantation and autoimmune disease.
    Bach JF
    C R Biol; 2006 Apr; 329(4):260-2. PubMed ID: 16644496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies for the therapeutic induction of tolerance.
    Waldmann H; Qin S; Cobbold SP
    Immunol Ser; 1993; 59():85-99. PubMed ID: 8461402
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunology. Gently soothing a savage immune system.
    Couzin J
    Science; 2002 Apr; 296(5567):456-8. PubMed ID: 11964457
    [No Abstract]   [Full Text] [Related]  

  • 18. T cell immunomodulation--the Holy Grail of therapeutic tolerance.
    Isaacs JD
    Curr Opin Pharmacol; 2007 Aug; 7(4):418-25. PubMed ID: 17611158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights into therapy with monoclonal antibodies in allograft transplantation.
    Schena FP
    Nephrol Dial Transplant; 1997; 12 Suppl 1():55-8. PubMed ID: 9075230
    [No Abstract]   [Full Text] [Related]  

  • 20. Antilymphocyte globulins in kidney transplantation.
    Kreis H
    Kidney Int Suppl; 1992 Oct; 38():S188-92. PubMed ID: 1405373
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.